LFB and NanoCarrier extend work on long-acting Factor VIIa
12 October 2011
Ian Haydock
Please Login to read the full article.
12 October 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- PROLOR Biotech files $75M shelf to advance PhII long-acting hGH
- Novo Nordisk looks to build existing business in Japan in launchless 2012
- US Phase III clearance moves Green Cross' Factor VIII closer to global market
- Japan to improve blood products independence through merger of plasma producers
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
